1997
DOI: 10.1159/000244445
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Trials of Surfactant Replacement in Europe

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1999
1999
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…The correlation between surfactant replacement and COD in our population suggests that surfactant therapy could not prevent RDS from developing into BPD. Two meta-analyses 1,27 failed to find that surfactant treatment, regardless of its type or mode, has any direct preventive effect on BPD that seems to be determined multifactorially and is not linked to RDS alone.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The correlation between surfactant replacement and COD in our population suggests that surfactant therapy could not prevent RDS from developing into BPD. Two meta-analyses 1,27 failed to find that surfactant treatment, regardless of its type or mode, has any direct preventive effect on BPD that seems to be determined multifactorially and is not linked to RDS alone.…”
Section: Discussionmentioning
confidence: 99%
“…New therapies introduced during the past decade have reduced mortality, but their effectiveness in reducing the occurrence of bronchopulmonary dysplasia (BPD) remains controversial. 1 BPD incidence varies in published studies from 4.6% to 72%. 2,3 This broad range may be explained by the heterogeneity of the studied populations, of management practices, or of disease definitions.…”
mentioning
confidence: 99%
“…We enrolled a total of 412 preterm infants, 237 from the development cohort 9 and 175 from the validation cohort 10 . The characteristics of the study population are shown in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…This is a secondary analysis of prospectively collected data from 12 neonatal intensive care units (NICUs). Preterm infants between 25° and 33 6 weeks of gestational age (GA) who were enrolled in two previous studies were included after validating their homogeneity 9,10 . Neonates were stratified by GA calculated from the first day of the last menstrual period: 25°− 27 6 ; 28 0 −30 6 ; 31 0 −33 6 weeks.…”
Section: Methodsmentioning
confidence: 99%
“…In systematic overviews of trials comparing prophylactic or early administration to surfactant treatment of established respiratory distress syndrome (RDS), infants who received prophylactic or early therapy had a decreased incidence of pneumothorax, pulmonary interstitial emphysema (PIE) and mortality [1,2,3]. Unfortunately, prophylaxis with surfactant would overtreat a large number of infants judged at risk for RDS.…”
Section: Introductionmentioning
confidence: 99%